Akari Therapeutics, Plc AKTX
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.94$8.64
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -152.38% | -56.43% | 12.60% | 21.75% | -- |
| Total Depreciation and Amortization | -- | -- | -- | -92.86% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9,173.79% | 879.92% | 939.94% | 4,174.36% | -- |
| Change in Net Operating Assets | -63.91% | -102.43% | -106.18% | -78.44% | -- |
| Cash from Operations | -19.28% | -2.33% | 15.81% | 34.95% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 109.90% | 109.90% | 110.11% | -- |
| Total Debt Repaid | 67.50% | 68.76% | 43.29% | -115.76% | -- |
| Issuance of Common Stock | 46.83% | -35.51% | -9.97% | -26.76% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 213.94% | -- | -- | -- | -- |
| Cash from Financing | 117.92% | -4.45% | 19.87% | -22.56% | -- |
| Foreign Exchange rate Adjustments | -142.86% | 0.00% | 125.00% | 100.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 454.41% | -86.04% | 319.56% | 111.99% | -- |